DEVON SOWA: Open Payments
NPI 1013442417 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 28 payments from 14 companies in 2025. Trend: 2023 $45 · 2024 $326 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Viatris Specialty LLC | 2 | $57 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: SYNTHROID, JARDIANCE, UBRELVY, YUPELRI, TRINTELLIX, VRAYLAR, SKYRIZI, Winlevi.
Industry payments across SC — which companies pay providers there.
